François Bailly

2.8k total citations
94 papers, 1.6k citations indexed

About

François Bailly is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, François Bailly has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 56 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in François Bailly's work include Hepatitis C virus research (58 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (34 papers). François Bailly is often cited by papers focused on Hepatitis C virus research (58 papers), Liver Disease Diagnosis and Treatment (36 papers) and Hepatitis B Virus Studies (34 papers). François Bailly collaborates with scholars based in France, Switzerland and United States. François Bailly's co-authors include C. Trépo, Fabien Zoulim, Cyrille Colin, Sandrine Touzet, Christian Trépo, Pierre Pradat, Laurent Cotte, Florence Persat, Méja Rabodonirina and François Chapuis and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Gastroenterology.

In The Last Decade

François Bailly

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Bailly France 21 993 965 195 141 125 94 1.6k
Joël Gozlan France 28 669 0.7× 1.4k 1.4× 421 2.2× 71 0.5× 54 0.4× 66 1.9k
Rafael Bárcena Spain 24 1.2k 1.3× 1.4k 1.4× 530 2.7× 87 0.6× 84 0.7× 94 2.0k
Jeong Kee Seo South Korea 23 217 0.2× 321 0.3× 152 0.8× 32 0.2× 39 0.3× 136 1.6k
José Antonio López Mira Spain 22 961 1.0× 962 1.0× 486 2.5× 23 0.2× 69 0.6× 64 1.6k
Eleanor Wilson United States 21 886 0.9× 1.1k 1.2× 510 2.6× 15 0.1× 40 0.3× 73 1.9k
E.V. Tsianos Greece 21 442 0.4× 645 0.7× 117 0.6× 29 0.2× 146 1.2× 54 1.3k
Inger Camilla Solberg Norway 21 235 0.2× 1.5k 1.5× 92 0.5× 11 0.1× 93 0.7× 29 2.3k
Manfred Wiese Germany 19 2.0k 2.0× 1.7k 1.8× 185 0.9× 8 0.1× 205 1.6× 48 2.4k
I Ocaña Spain 31 150 0.2× 934 1.0× 1.1k 5.4× 85 0.6× 44 0.4× 89 2.4k

Countries citing papers authored by François Bailly

Since Specialization
Citations

This map shows the geographic impact of François Bailly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Bailly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Bailly more than expected).

Fields of papers citing papers by François Bailly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Bailly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Bailly. The network helps show where François Bailly may publish in the future.

Co-authorship network of co-authors of François Bailly

This figure shows the co-authorship network connecting the top 25 collaborators of François Bailly. A scholar is included among the top collaborators of François Bailly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Bailly. François Bailly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lejeune, Olivier, et al.. (2025). A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder. The American Journal of Drug and Alcohol Abuse. 51(1). 68–72.
2.
Dumortier, Jérôme, Olivier Guillaud, Olivier Boillot, et al.. (2025). Phosphatidylethanol and urinary ethylglucuronide to assess alcohol consumption after liver transplantation. Liver Transplantation. 32(1). 104–106.
3.
Barré, Tangui, Philippe Mathurin, Camélia Protopopescu, et al.. (2019). Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project. International Journal of Drug Policy. 72. 61–68. 21 indexed citations
4.
Protopopescu, Camélia, Philippe Sogni, Issifou Yaya, et al.. (2019). HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort). AIDS and Behavior. 24(4). 1069–1084. 13 indexed citations
5.
Naassïla, Mickaël, Mikaïl Nourredine, Alexandre Louvet, et al.. (2019). Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain. Frontiers in Pharmacology. 10. 627–627. 36 indexed citations
6.
Virlogeux, Victor, Laure Choupeaux, Pierre Pradat, et al.. (2016). Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay. Digestive and Liver Disease. 48(11). 1351–1356. 4 indexed citations
7.
Piroth, Lionel, Anne Marie Taburet, Corine Vincent, et al.. (2015). High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. Clinical Infectious Diseases. 61(5). 817–825. 10 indexed citations
8.
Park, Ji‐Hye, M. Courtois, François Bailly, et al.. (2015). Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods. PLoS ONE. 10(10). e0141010–e0141010. 9 indexed citations
9.
Zoulim, Fabien & François Bailly. (2012). New approaches to the management of hepatitis C in haemophilia in 2012. Haemophilia. 18(s4). 28–33. 21 indexed citations
10.
Zoulim, Fabien, François Bailly, Margaret Johnson, & C. M. Kessler. (2012). Treatment of human immunodeficiency virus and hepatitis B virus infections. Haemophilia. 18(s4). 34–37. 4 indexed citations
11.
Vanhems, Philippe, et al.. (2006). Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France. European Journal of Public Health. 17(3). 263–271. 14 indexed citations
12.
Broussolle, C., et al.. (1999). Infection par le virus de l'hépatite C et pathologies thyroïdiennes. La Revue de Médecine Interne. 20(9). 766–773. 16 indexed citations
13.
Cotte, Laurent, Méja Rabodonirina, François Chapuis, et al.. (1999). Waterborne Outbreak of Intestinal Microsporidiosis in Persons with and without Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 180(6). 2003–2008. 149 indexed citations
14.
Poynard, Thierry, Sylvie Chevret, J. Moussalli, et al.. (1999). A short induction regimen of interferon‐α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. Journal of Viral Hepatitis. 6(5). 381–386. 6 indexed citations
15.
Colin, Cyrille, et al.. (1998). [National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group].. PubMed. 19(4). 217–22. 2 indexed citations
16.
Bailly, François, et al.. (1997). Uncommon side‐effects of interferon. Journal of Viral Hepatitis. 4(s1). 89–94. 10 indexed citations
17.
Trabaud, Mary‐Anne, François Bailly, Giuseppe Colucci, & C. Trépo. (1996). Stability of hepatitis C virus RNA in serum from samples collected in a closed‐tube system for serum separation and transport, as measured by a quantitative competitive PCR assay. Journal of Viral Hepatitis. 3(4). 207–209. 7 indexed citations
18.
Cotte, Laurent, et al.. (1996). Cytomegalovirus DNA level on biopsy specimens during treatment of cytomegalovirus gastrointestinal disease. Gastroenterology. 111(2). 439–444. 14 indexed citations
19.
Trépo, C., François Bailly, & T Bizollon. (1996). Treatment of chronic hepatitis C: another therapeutic option. Nephrology Dialysis Transplantation. 11(supp4). 62–64. 4 indexed citations
20.
Trépo, C., François Habersetzer, François Bailly, et al.. (1994). Interferon therapy for hepatitis C. Antiviral Research. 24(2-3). 155–163. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joël Gozlan Breakdown of academic impact, for papers by Rafael Bárcena Breakdown of academic impact, for papers by Jeong Kee Seo Breakdown of academic impact, for papers by José Antonio López Mira Breakdown of academic impact, for papers by Eleanor Wilson Breakdown of academic impact, for papers by E.V. Tsianos Breakdown of academic impact, for papers by Inger Camilla Solberg Breakdown of academic impact, for papers by Manfred Wiese Breakdown of academic impact, for papers by I Ocaña
Rankless by CCL
2026